Literature DB >> 16946300

Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

Ting-Lei Gu1, Valerie L Goss, Cynthia Reeves, Lana Popova, Julie Nardone, Joan Macneill, Denise K Walters, Yi Wang, John Rush, Michael J Comb, Brian J Druker, Roberto D Polakiewicz.   

Abstract

The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene. To date, 8 fusion partners of FGFR1 have been identified. However, no primary leukemia cell lines were identified that contain any of these fusions. Here, we screened more than 40 acute myeloid leukemia cell lines for constitutive phosphorylation of STAT5 and applied an immunoaffinity profiling strategy to identify tyrosine-phosphorylated proteins in the KG-1 cell line. Mass spectrometry analysis of KG-1 cells revealed aberrant tyrosine phosphorylation of FGFR1. Subsequent analysis led to the identification of a fusion of the FGFR1OP2 gene to the FGFR1 gene. Small interfering RNA (siRNA) against FGFR1 specifically inhibited the growth and induced apoptosis of KG-1 cells. Thus, the KG-1 cell line provides an in vitro model for the study of FGFR1 fusions associated with leukemia and for the analysis of small molecule inhibitors against FGFR1 fusions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946300     DOI: 10.1182/blood-2006-06-026666

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.

Authors:  Mingqiang Ren; Haiyan Qin; Ruizhe Ren; Josephine Tidwell; John K Cowell
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

2.  FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.

Authors:  Haiyan Qin; Qing Wu; John K Cowell; Mingqiang Ren
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

Review 3.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

4.  RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.

Authors:  Jeffrey W Tyner; Denise K Walters; Stephanie G Willis; Mary Luttropp; Jason Oost; Marc Loriaux; Heidi Erickson; Amie S Corbin; Thomas O'Hare; Michael C Heinrich; Michael W Deininger; Brian J Druker
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

5.  Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

Authors:  Julie W Reeser; Dorrelyn Martin; Jharna Miya; Esko A Kautto; Ezra Lyon; Eliot Zhu; Michele R Wing; Amy Smith; Matthew Reeder; Eric Samorodnitsky; Hannah Parks; Karan R Naik; Joseph Gozgit; Nicholas Nowacki; Kurtis D Davies; Marileila Varella-Garcia; Lianbo Yu; Aharon G Freud; Joshua Coleman; Dara L Aisner; Sameek Roychowdhury
Journal:  J Mol Diagn       Date:  2017-08-09       Impact factor: 5.568

6.  Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies.

Authors:  Joseph M Gozgit; Matthew J Wong; Scott Wardwell; Jeffrey W Tyner; Marc M Loriaux; Qurish K Mohemmad; Narayana I Narasimhan; William C Shakespeare; Frank Wang; Brian J Druker; Tim Clackson; Victor M Rivera
Journal:  Mol Cancer Ther       Date:  2011-04-11       Impact factor: 6.261

7.  Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines.

Authors:  Carolien van Alphen; Jacqueline Cloos; Robin Beekhof; David G J Cucchi; Sander R Piersma; Jaco C Knol; Alex A Henneman; Thang V Pham; Johan van Meerloo; Gert J Ossenkoppele; Henk M W Verheul; Jeroen J W M Janssen; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2020-02-26       Impact factor: 5.911

8.  Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.

Authors:  Audrey Lin; Akishige Hokugo; Jae Choi; Ichiro Nishimura
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

9.  Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer.

Authors:  Juliann Chmielecki; Martin Peifer; Peilin Jia; Nicholas D Socci; Katherine Hutchinson; Agnes Viale; Zhongming Zhao; Roman K Thomas; William Pao
Journal:  Nucleic Acids Res       Date:  2010-06-29       Impact factor: 16.971

10.  Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Authors:  Taro Hitosugi; Sumin Kang; Matthew G Vander Heiden; Tae-Wook Chung; Shannon Elf; Katherine Lythgoe; Shaozhong Dong; Sagar Lonial; Xu Wang; Georgia Z Chen; Jianxin Xie; Ting-Lei Gu; Roberto D Polakiewicz; Johannes L Roesel; Titus J Boggon; Fadlo R Khuri; D Gary Gilliland; Lewis C Cantley; Jonathan Kaufman; Jing Chen
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.